"description","uuid:ID","label","id","name","text","instanceType"
"Main objective","099c996d-495b-443b-8cdf-8f35887371dd","","Objective_1","OBJ1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","OBJECTIVE"
"Safety","f5b85b30-e829-4b42-9962-524198bee3c8","","Objective_2","OBJ2","To document the safety profile of the xanomeline TTS.","OBJECTIVE"
"Behaviour","c1ba7ea9-2255-4748-97ac-b2e50c1aee28","","Objective_3","OBJ3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","OBJECTIVE"
